Canopy Growth Announces Results of Annual General and Special Shareholder Meeting

Rhea-AI Summary

Canopy Growth Corporation held its annual general and special meeting on September 15, 2022, with a total of 256,426,802 shares voted, representing 53.42% of its outstanding shares. All items on the agenda, including director elections and auditor re-appointment, were approved. Key nominees like Judy A. Schmeling received 96.66% support. The meeting also saw approval for the Employee Stock Purchase Plan and a non-binding compensation resolution for executives. For detailed voting results, refer to the Company's Report of Voting Results.

Positive

• Shareholders approved all agenda items with majority votes, indicating strong support for management decisions.
• Re-appointment of KPMG LLP as auditors for the 2023 fiscal year fosters continuity in financial oversight.
• Approval of the Employee Stock Purchase Plan can enhance employee engagement and retention.

Negative

• None.

SMITHS FALLS, ON, Sept. 16, 2022 /PRNewswire/ - Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) ("Canopy Growth" or the "Company") today announced the voting results from its annual general and special meeting of shareholders held on September 15, 2022 (the "Meeting").

A total of 256,426,802 common shares of the Company, representing 53.42% of the issued and outstanding common shares of the Company, were voted in connection with the Meeting by shareholders and proxy holders.

All of the matters put forward before the Company's shareholders for consideration and approval, as set out in the Company's definitive proxy statement dated July 28, 2022 (the "Proxy Statement"), were approved by the requisite majority of votes cast at the Meeting, as further detailed below.

Each of the directors listed as a nominee in the Proxy Statement was elected at the Meeting to serve as a director of the Company until the Company's next annual shareholders meeting or until his or her successor is duly elected or appointed. The detailed results of the vote for the election of directors held at the Meeting are set out below:

Name of Nominee	Votes cast FOR	% Votes FOR	Votes AGAINST	% Votes AGAINST
Judy A. Schmeling	174,936,094	96.66 %	6,040,153	3.34 %
David Klein	172,965,207	95.57 %	8,011,041	4.43 %
Garth Hankinson	173,043,911	95.62 %	7,932,337	4.38 %
Robert L. Hanson	169,930,747	93.91 %	11,028,826	6.09 %
David Lazzarato	174,853,021	96.62 %	6,123,027	3.38 %
James A. Sabia	171,154,369	94.57 %	9,821,879	5.43 %
Theresa Yanofsky	170,590,929	94.26 %	10,385,319	5.74 %

Canopy Growth shareholders also approved the re-appointment of KPMG LLP as the Company's auditors for the 2023 fiscal year and authorized the board of directors to fix its remuneration.

In addition, Canopy Growth shareholders approved the renewal of the Company's Employee Stock Purchase Plan.

Canopy Growth shareholders also approved an advisory (non-binding) resolution on the compensation of the Company's named executive officers.

For complete results on all matters voted on at the Meeting, please consult the Company's Report of Voting Results which will be filed on the Company's SEDAR profile at www.sedar.com, and the Company's Form 8-K which will be filed on EDGAR at www.sec.gov/edgar.

About Canopy Growth Corporation

Canopy Growth (TSX:WEED, NASDAQ:CGC) is a world-leading diversified cannabis and cannabinoid-based consumer product company, driven by a passion to improve lives, end prohibition, and strengthen communities by unleashing the full potential of cannabis. Leveraging consumer insights and innovation, we offer product varieties in high-quality dried flower, oil, softgel capsule, infused beverage, edible, and topical formats, as well as vaporizer devices by Canopy Growth and industry-leader Storz & Bickel. Our global medical brand, Spectrum Therapeutics, sells a range of full-spectrum products using its colour-coded classification system and is a market leader in both Canada and Germany. Through our award-winning Tweed and Tokyo Smoke banners, we reach our adult-use consumers and have built a loyal following by focusing on top quality products and meaningful customer relationships. Canopy Growth has entered into the health and wellness consumer space in key markets including Canada, the United States, and Europe through BioSteel sports nutrition, and This Works skin and sleep solutions, and has introduced additional hemp-derived CBD products to the United States through our First & Free and Martha Stewart CBD brands. Canopy Growth has an established partnership with Fortune 500 alcohol leader Constellation Brands. For more information, visit www.canopygrowth.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/canopy-growth-announces-results-of-annual-general-and-special-shareholder-meeting-301625998.html

SOURCE Canopy Growth Corporation

FAQ

What were the results of Canopy Growth's shareholder meeting on September 15, 2022?

All proposed items, including director elections and auditor re-appointment, were approved by the shareholders.

How many shares were voted at Canopy Growth's meeting?

256,426,802 shares were voted, representing 53.42% of the outstanding shares.

Who was elected as directors at Canopy Growth's annual meeting?

Directors including Judy A. Schmeling and David Klein were elected with significant majority votes.

What significant plans were approved at Canopy Growth's shareholder meeting?

The Employee Stock Purchase Plan and a non-binding resolution on executive compensation were approved.